Texas Medical Technology invests in Olive Diagnostics, the World’s First Hands-free, Toilet-mounted Urinalysis Device

By AIT News Desk On Feb 1, 2022

By investing in Olive Diagnostics, Texas Medical Technology actively supports providing people with practical insights into their own personal health

Texas Medical Technology, a leading manufacturer and distributor of medical supplies and equipment, announces a substantial investment in Olive Diagnostics, a medtech company transforming at-home urinalysis testing with a passive, continuous home monitoring system mounted on a toilet. Olive’s KG device is a hands-free, non-invasive, artificial intelligence (AI)-based device that provides remote 24/7 diagnostics by detecting urine’s molecular composition.

Latest Aithority Insights : Mainframe-to-Cloud Migration Poised to Unlock Data

“More importantly, by using simple prevention and detection measures such as the KG device, we are able to improve population health and begin exploring further opportunities such as predictive analytics with home-based diagnostics.”

Self-monitoring one’s health plays a crucial role in our ability to prevent disease and improve healthcare. With new technology and the digitization of healthcare, simple and swift home-based diagnostics can serve as a central vehicle for this, where regularly self-monitoring the user’s urine provides users with early disease detection for a plethora of potential issues, including UTI, kidney stones, heart failure, and dehydration.

Texas Medical Technology’s investment in Olive Diagnostics will support the company’s mission to help people and businesses sustain a safer, healthier lifestyle. Olive’s KG device, mounted on any toilet, serves as the first hands-free digital urinalysis tool in the world. The company’s cloud-based AI system calculates molecule concentrations in the user’s urine, utilizing proprietary algorithms to analyze and track collected data, alerting the user of any changes or anomalies.

The diagnostic tool combines the best in biochemical and spectroscopy research with the latest in biomedical science, AI, and data analytics. Clinical trials at Hadassah Ein Kerem in Jerusalem, run and analyzed by third party Technostat, confirmed the Olive system’s ability to effectively detect protein in urine in over 900 samples, proving more effective than traditional urine sticks. The diagnostic tool is currently utilized by four assisted living facilities in Europe.

The partnership between Texas Medical Technology and Olive Diagnostics is part of a wider commitment towards building MetaHealth, a virtual platform akin to the Metaverse, which will ultimately allow decision makers to execute the needs of healthcare networks through an avatar. This Metaverse for health will become pivotal in the future to change, enhance, and possibly transform health care.

Texas Medical Technology was established to meet the soaring demand for personal protective equipment during the COVID-19 pandemic. The company now has a 144,000-square-foot factory in Houston, Texas that employs 550 workers from 53 countries, including refugees assisted by the YMCA of Greater Houston and the Catholic Charities of the Archdiocese of Galveston-Houston. Keeping in line with their mission to aid disadvantaged communities across the country, the company also recently announced joint ventures with The Modoc Nation of Oklahoma.

Browse The Complete News About Aithority: Echoworx Reveals Trends in Email Security Strategies

“Providing people with practical insights into their own personal health data will be a huge leap for today’s peace of mind,” says Corey Katz, Co-Founder of Olive Diagnostics. “More importantly, by using simple prevention and detection measures such as the KG device, we are able to improve population health and begin exploring further opportunities such as predictive analytics with home-based diagnostics.”

“We’ve been incredibly impressed with Olive’s capabilities to optimize home diagnostic tools at a time when we need it most,” says Omri Shafran, Founder & CEO of Texas Medical Technology. “Keeping people informed about their bodily functions on a continuous basis will become a central part of health systems in the future, and I’m confident Olive Diagnostics will help spearhead that push with new technologies constantly being discovered.”

[To share your insights with us, please write to sghosh@martechseries.com]